{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:56:05Z","timestamp":1791251765337,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.2515\/therapie\/2015016","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T11:32:26Z","timestamp":1428579146000},"page":"229-234","source":"Crossref","is-referenced-by-count":5,"title":["New Methadone Formulation in France: Results from 5 Years of Utilization"],"prefix":"10.1016","volume":"70","author":[{"given":"Quentin","family":"Boucherie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Frauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mallaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.2515\/therapie\/2015016_bb3010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J Neurosci Rural Pract"},{"key":"10.2515\/therapie\/2015016_bb3015","unstructured":"World Health Organization. Atlas on substance use: resources for the prevention and treatment of substance use disorders. Chapter 3: Substance-related disorders - prevention and control 2010. ISBN: 978 92 4 150061 6 http:\/\/www.who.int\/substance_abuse\/publications\/treatment\/en\/ Accessed February 9th, 2015"},{"key":"10.2515\/therapie\/2015016_bb3020","series-title":"Methadone Maintenance Treatment for Opioid Dependence","author":"College of Physicians and Surgeons of Ontario","year":"2010"},{"key":"10.2515\/therapie\/2015016_bb3025","doi-asserted-by":"crossref","first-page":"e41181","DOI":"10.1371\/journal.pone.0041181","article-title":"Using poison center exposure calls to predict methadone poisoning deaths","volume":"7","author":"Dasgupta","year":"2012","journal-title":"PLoS One"},{"key":"10.2515\/therapie\/2015016_bb3030","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2007"},{"issue":"1","key":"10.2515\/therapie\/2015016_bb3035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","article-title":"Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006","volume":"39","author":"Nosyk","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.2515\/therapie\/2015016_bb3040","series-title":"Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care","author":"Royal College of General Practitioners","year":"2011"},{"key":"10.2515\/therapie\/2015016_bb3045","unstructured":"Soci\u00e9t\u00e9 Scientifique des Pharmaciens Francophones. La m\u00e9thadone : bien prescrire, bien d\u00e9livrer. E-news m\u00e9decin-pharmacien 2009 http:\/\/sspf.claroline.com\/claroline\/backends\/download.php?url=L2VuZXdzXzIwMDkvbel0aGFkb25lX19wcmVzY3JpcmVfZXRfZOlsaXZyZXIucGRm&cidReset=true&cidReq=NEWS Accessed February 9th, 2015 (2 pages)."},{"key":"10.2515\/therapie\/2015016_bb3050","year":"2013"},{"issue":"3","key":"10.2515\/therapie\/2015016_bb3055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsat.2013.10.006","article-title":"From methadone to buprenorphine: changes during a 10year period within a national opioid maintenance treatment programme","volume":"46","author":"Riksheim","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"10.2515\/therapie\/2015016_bb3060","unstructured":"Commission Nationale des Stup\u00e9fiants et des Psychotropes. Compte-rendu de la s\u00e9ance du 21 octobre 2014. Paris http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/b6fa9fda146dc1ba87818c4f3e215e0e.pdf Accessed February 9th, 2015 (14 pages)."},{"key":"10.2515\/therapie\/2015016_bb3065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jsat.2012.11.006","article-title":"Effectiveness of drug tests in outpatients starting opioid substitution therapy","volume":"44","author":"Dupouy","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"10.2515\/therapie\/2015016_bb3070","author":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9","year":"2004"},{"issue":"2","key":"10.2515\/therapie\/2015016_bb3075","first-page":"92","article-title":"Methadone and oral health--a brief review","volume":"85","author":"Brondani","year":"2011","journal-title":"J Dent Hyg"},{"issue":"1","key":"10.2515\/therapie\/2015016_bb3080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2011.0048","article-title":"Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients","volume":"7","author":"Mysels","year":"2011","journal-title":"J Opioid Manag"},{"key":"10.2515\/therapie\/2015016_bb3085","unstructured":"Commission Nationale des Stup\u00e9fiants et des Psychotropes. M\u00e9thadone g\u00e9lule : rapport \u00e9tude observationnelle+bilan \u00e0 2 ans de commercialisation. Addendum au compte rendu du 29 avril 2010. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/14f894f589f68d73eb7217ac3bdc39d3.pdf Accessed February 9th, 2015 (13 pages)."},{"issue":"4","key":"10.2515\/therapie\/2015016_bb3090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.acvd.2009.02.005","article-title":"Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database","volume":"102","author":"Tuppin","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"10.2515\/therapie\/2015016_bb3095","series-title":"Health reimbursed national system: data on reimbursed drug from 2008 to 2011","author":"Ameli","year":"2012"},{"key":"10.2515\/therapie\/2015016_bb3100","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. National Report 2012 (2011 data) to the EMCDDA by the Reitox National Focal Point France. New Development, Trends and in-depth information on selected issues. http:\/\/www.emcdda.europa.eu\/\u2026cfm\/att_213784_EN_Austria_NR2012.pdf Accessed February 9th, 2015 (236 pages)"},{"issue":"2","key":"10.2515\/therapie\/2015016_bb3105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2515\/therapie\/2013020","article-title":"New formulation of methadone for opioid dependence in France: acceptability and diversion\/misuse liability","volume":"68","author":"Eiden","year":"2013","journal-title":"Therapie"},{"issue":"3","key":"10.2515\/therapie\/2015016_bb3110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","article-title":"Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment, findings of the German randomized controlled trial","volume":"112","author":"Eiroa-Orosa","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"1-3","key":"10.2515\/therapie\/2015016_bb3115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jad.2006.09.017","article-title":"Depression in methadone maintenance treatment patients: rate and risk factors","volume":"99","author":"Peles","year":"2007","journal-title":"J Affect Disord"},{"issue":"3","key":"10.2515\/therapie\/2015016_bb3120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.drugalcdep.2004.12.001","article-title":"Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking","volume":"78","author":"Teesson","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"2-3","key":"10.2515\/therapie\/2015016_bb3125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugalcdep.2007.03.008","article-title":"Benzodiazepine prescription for patients in opioid maintenance treatment in Norway","volume":"90","author":"Bramness","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.2515\/therapie\/2015016_bb3130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1747-597X-7-11","article-title":"Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan","volume":"7","author":"Lee","year":"2012","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.2515\/therapie\/2015016_bb3135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2165\/11531570-000000000-00000","article-title":"Assessment of abuse potential of benzodiazepines from a prescription database using \u201cdoctor shopping\u201d as an indicator","volume":"24","author":"Pradel","year":"2010","journal-title":"CNS Drugs"},{"key":"10.2515\/therapie\/2015016_bb3140","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann","year":"2013","journal-title":"Pain Physician"},{"key":"10.2515\/therapie\/2015016_bb3145","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Medicine"},{"key":"10.2515\/therapie\/2015016_bb3150","author":"Commission Nationale des Stup\u00e9fiants et des Psychotropes","year":"2014"},{"issue":"4","key":"10.2515\/therapie\/2015016_bb3155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1472-8206.2011.00950.x","article-title":"Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey","volume":"26","author":"Frauger","year":"2012","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T12:00:17Z","timestamp":1554292817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716310617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0040595716310617"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015016","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}